ASTHMA-Educator Mobile Application Manage Asthma

Overview

Through this study, the investigators developed the ASTHMA-Educator mobile application, and evaluated its use among adult asthma patients at Montefiore.

Full Title of Study: “The ASTHMA-Educator: A Novel Algorithmic Software Tool to Help Manage Asthma”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Health Services Research
    • Masking: None (Open Label)
  • Study Primary Completion Date: March 15, 2018

Detailed Description

Through this study, the investigators developed the ASTHMA-Educator mobile application, and evaluated its use through 2 phases: 1) Phase 1 = process outcomes evaluation with 30 patients); and 2) Phase 2 (longitudinal clinical evaluation with 40 patients receiving the intervention at baseline, 2 months, 4 months, and 6 months). The study's primary outcome is asthma control.

Interventions

  • Other: ASTHMA-Educator mobile application
    • The on-site delivered ASTHMA-Educator mobile application.

Arms, Groups and Cohorts

  • Experimental: ASTHMA-Educator arm
    • The ASTHMA-Educator mobile application for patient-centered asthma education. The application is administered via on-site iPad (tablet).

Clinical Trial Outcome Measures

Primary Measures

  • Change from baseline asthma control to 2, 4, and 6 months
    • Time Frame: Baseline, 2 months, 4 months, 6 months
    • Asthma symptom burden as measured by the Asthma Control Test

Secondary Measures

  • Change from baseline asthma knowledge to immediately post-intervention, 2 months, 4 months, and 6 months
    • Time Frame: Baseline, immediately post-intervention, 2 months, 4 months, 6 months
    • Asthma knowledge as measured by the validated Asthma Knowledge Questionnaire
  • Patient satisfaction measured by the Client Satisfaction Questionnaire-8
    • Time Frame: Immediately post-intervention at the baseline visit, 2 months, 4 months, 6 months
    • Patient satisfaction measured by the Client Satisfaction Questionnaire-8
  • Time spent in using the mobile application
    • Time Frame: Immediately post-intervention at the baseline visit
    • Time spent in using the mobile application
  • Asthma quality of life measured by the mini-Asthma Quality of Life Questionnaire (mini-AQLQ)
    • Time Frame: Baseline, 2 months, 4 months, 6 months
    • Patients’ asthma quality of life measured by the mini-Asthma Quality of Life Questionnaire (mini-AQLQ)
  • Asthma emergency department visits
    • Time Frame: Baseline, 2 months, 4 months, 6 months
    • Asthma emergency department visits
  • Asthma hospitalizations
    • Time Frame: Baseline, 2 months, 4 months, 6 months
    • Asthma hospitalizations
  • Asthma-related steroid courses
    • Time Frame: Baseline, 2 months, 4 months, 6 months
    • Asthma-related steroid courses

Participating in This Clinical Trial

Inclusion Criteria

Adults (>18 years) with: (a) severe asthma (i.e. at least one asthma-related ED visit and/or hospitalization in the previous year); (b) access to a smartphone with short message service (SMS) capability; (c) English speaking; (d) able to give informed consent. Exclusion Criteria:

(a) use of oral corticosteroids in the 2 weeks prior to the baseline visit; (b) pregnancy; (c) severe psychiatric or cognitive problems that would prohibit an individual from understanding and completing the protocol; and (d) patients that previously received the ASTHMAXcel application.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Montefiore Medical Center
  • Provider of Information About this Clinical Study
    • Principal Investigator: Sunit P. Jariwala, Associate Professor (Medicine) – Montefiore Medical Center
  • Overall Official(s)
    • Sunit Jariwala, Principal Investigator, Montefiore Medical Center

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.